Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

AstraZeneca (LSE:AZN) FTSE 100 Large-Cap Stock in Focus as Oncology Growth and Pipeline Catalysts Accelerate

• The immediate market question is whether the latest operating or portfolio signal can translate into stronger financial performance, improved cash generation or better visibility over the next reporting period.

Ankur Sharma | 12 November 2026

ConvaTec Group (LSE:CTEC) FTSE 100 Large-Cap Stock in Focus as Healthcare Demand and Margins Matter

• The immediate market question is whether the latest operating or portfolio signal can translate into stronger financial performance, improved cash generation or better visibility over the next reporting period.

Ankur Sharma | 12 November 2026

Genus (LSE:GNS): Could the PRRS-Resistant Pig Open the Next Chapter in Animal Genetics?

Genus plc shares fell 4.18% to around 2,290.0p on 12 Nov 2026, a decline of 100.00p, based on market data. The move comes after the company's FY26 results published in September 2026, which reported higher adjusted profit and the launch of a £60 million …

Divya Sood | 12 November 2026

Eco Animal Health (LSE:EAH) Steps Into Vaccines After Its Antibiotic Franchise

Eco Animal Health Group PLC shares rose 5.10% on 11 Nov 2026, with LSE:EAH among the notable risers on the day. The move follows the company's results for the year ended 31 March 2026, which showed growth acrossRevenueand earnings.

Ankur Sharma | 12 November 2026

Avacta (LSE:AVCT) Advances a New Generation of Tumour-Targeted Cancer Medicines

Avacta Group PLC shares rose 10.56% on 11 Nov 2026, with LSE:AVCT among the notable risers in the market snapshot. The move follows the company's half-year update, which outlined clinical progress across its pre|CISION peptide drug conjugate pipeline.

Ankur Sharma | 12 November 2026

Oxford Nanopore Technologies PLC (LSE:ONT): Mid-Cap Market Focus | FTSE 250 — Sequencing Growth Keeps Oxford Nanopore in Focus After a Strong Year

Oxford Nanopore Technologies PLC is in focus on 11 November 2026 as investors reassess the latest operating signals, share-price momentum and the next catalysts for LSE:ONT. The company is listed on the London Stock Exchange and sits in the FTSE 250 universe. With an …

Ankur Sharma | 12 November 2026

Genus PLC (LSE:GNS): Mid-Cap Market Focus | FTSE 250 — Animal Genetics and Healthcare Demand Keep Genus in the Mid-Cap Spotlight

Genus PLC is in focus on 11 November 2026 as investors reassess the latest operating signals, share-price momentum and the next catalysts for LSE:GNS. The company is listed on the London Stock Exchange and sits in the FTSE 250 universe. With an estimatedMarket Capitalisationof …

Ankur Sharma | 12 November 2026

FTSE 250 International Biotechnology Trust (LSE:IBT) Draws Attention as Biotech Risk Appetite Improves

International Biotechnology Trust remained in focus as a healthcareInvestmenttrust with exposure to biotechnology and life sciences.

Ankur Sharma | 12 November 2026

FTSE 250 PureTech Health (LSE:PRTC) Remains in Focus as Clinical and Commercial Milestones Approach

PureTech Health remained in focus as a mid-cap healthcare company centred on therapeutic development and platform assets.

Ankur Sharma | 12 November 2026

FTSE AIM 100 Mid Cap Advanced Medical Solutions Group plc (LSE:AMS) in Focus Today: What Is Driving Attention and What Investors Are Watching Next?

Advanced Medical Solutions remains in focus following the strategic interest around the company and its tissue-healing technology portfolio. The shares were near their recent highs, keeping investors focused on the potential value of theBusinessand any corporate developments. That makes LSE:AMS relevant today because investors …

Ankur Sharma | 12 November 2026
Support

Hi! How can we help you today?

Loading…